Correlation Between Eliem Therapeutics and Alector
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Alector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Alector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Alector, you can compare the effects of market volatilities on Eliem Therapeutics and Alector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Alector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Alector.
Diversification Opportunities for Eliem Therapeutics and Alector
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eliem and Alector is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Alector in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alector and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Alector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alector has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Alector go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Alector
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Alector. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 1.22 times less risky than Alector. The stock trades about -0.29 of its potential returns per unit of risk. The Alector is currently generating about -0.17 of returns per unit of risk over similar time horizon. If you would invest 507.00 in Alector on August 27, 2024 and sell it today you would lose (113.00) from holding Alector or give up 22.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Eliem Therapeutics vs. Alector
Performance |
| Timeline |
| Eliem Therapeutics |
| Alector |
Eliem Therapeutics and Alector Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Alector
The main advantage of trading using opposite Eliem Therapeutics and Alector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Alector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alector will offset losses from the drop in Alector's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Alector vs. Eliem Therapeutics | Alector vs. HCW Biologics | Alector vs. Scpharmaceuticals | Alector vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |